<DOC>
	<DOCNO>NCT00966823</DOCNO>
	<brief_summary>The purpose phase 2 limited study examine whether prenatal intervention correct lung underdevelopment associate severe diaphragmatic hernia .</brief_summary>
	<brief_title>Fetal Tracheal Balloon Study Diaphragmatic Hernia</brief_title>
	<detailed_description>Congenital diaphragmatic hernia ( CDH ) traditionally associate high mortality rate . Most infant die pulmonary hypoplasia severe pulmonary hypertension . This led correction CDH pulmonary hypoplasia birth . Unfortunately , maternal morbidity open fetal surgery significant fetal mortality high ( &gt; 60 % ) . Moreover , result postnatal therapy CDH improve dramatically , less 20 % survival several decade ago 70 % today . Fetal intervention evolve well , minimally invasive approach involve single endoscopic port occlusion fetal trachea . While considerably decrease morbidity fetal mortality utero procedure , result exceed overall ( i.e. , non-stratified ) result contemporary postnatal treatment . Most recently , multicentric cooperative study ( Eurofoetus ) conduct clinical trial compare postnatal treatment endoscopic fetal tracheal occlusion severe form CDH . Results Eurofoetus trial recent retrospective review involve European North-American center show follow : 1 ) It possible identify specific subgroup fetuses CDH survival predict less 10 % , despite current method postnatal treatment , 2 ) Survival fetus predict postnatal survival 8 % &gt; 50 % follow endoscopic fetal tracheal occlusion , 3 ) Fetal tracheal occlusion group result increase lung size ( LHR ) , average 0.7 pre-intervention , 1.7 post-intervention . Based available research literature , result Eurofoetus trial , institution 's experience endoscopic fetal surgery , hypothesize high risk group fetuses congenital diaphragmatic hernia , chance survival estimate less 10 % , endoscopic fetal tracheal occlusion late second trimester , reversal occlusion mid-third trimester , allow catch-up lung growth maturation convert condition one intermediate good prognosis ( predicted survival 50-60 % ) . We propose offer form treatment , FDA-approved Investigational Device Exemption ( G080077 ) , eligible patient , case-by-case basis , discussion multidisciplinary board .</detailed_description>
	<mesh_term>Hernia</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Hernia , Diaphragmatic</mesh_term>
	<mesh_term>Hernias , Diaphragmatic , Congenital</mesh_term>
	<criteria>Singleton pregnancy Isolated congenital diaphragmatic hernia Normal karyotype ( amniocentesis ) Initial diagnosis 26 week gestation Competent cervix Severity CDH : lungtohead ratio ( LHR ) â‰¤0.8 2226 week gestation Liver herniation chest Informed consent Preterm labor , premature rupture membrane amniotic leak Significant maternal morbidity Minor ( &lt; 18 year )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Diaphragm</keyword>
	<keyword>Trachea</keyword>
	<keyword>Lung development</keyword>
	<keyword>Lung growth</keyword>
	<keyword>Tracheal occlusion</keyword>
	<keyword>ECMO</keyword>
	<keyword>Neonatal death</keyword>
</DOC>